Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Inventory: 2016-2024

Historic Inventory for Fortress Biotech (FBIO) over the last 9 years, with Dec 2024 value amounting to $14.9 million.

  • Fortress Biotech's Inventory rose 6.68% to $12.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year increase of 6.68%. This contributed to the annual value of $14.9 million for FY2024, which is 46.42% up from last year.
  • Fortress Biotech's Inventory amounted to $14.9 million in FY2024, which was up 46.42% from $10.2 million recorded in FY2023.
  • In the past 5 years, Fortress Biotech's Inventory registered a high of $14.9 million during FY2024, and its lowest value of $1.4 million during FY2020.
  • For the 3-year period, Fortress Biotech's Inventory averaged around $13.1 million, with its median value being $14.2 million (2022).
  • Its Inventory has fluctuated over the past 5 years, first soared by 602.42% in 2021, then fell by 27.92% in 2023.
  • Over the past 5 years, Fortress Biotech's Inventory (Yearly) stood at $1.4 million in 2020, then skyrocketed by 602.42% to $9.9 million in 2021, then soared by 43.57% to $14.2 million in 2022, then fell by 27.92% to $10.2 million in 2023, then spiked by 46.42% to $14.9 million in 2024.